Executive Director, Oncology Research & Discovery

BioSpace; South San Francisco (CA); In loco; USD 270.000 - 365.000; Tempo pieno

Vantaggi offerti da questo lavoro

Retirement and Savings Plan

Stock-based incentives

Award-winning time-off plans

Flexible work models

Descrizione del lavoro

Amgen is seeking an Executive Director of Oncology Research to lead the discovery and development of novel cancer therapies. You will drive strategy, build high-performing teams, and shape next-generation oncology programs, focusing on ADCs and beyond.

This high-visibility role offers opportunities to partner across functions and externally to advance medicines that improve patient lives. We value inclusive leadership, scientific excellence, and a patient-centric approach as we pursue a bold

Competenze

• PhD with 6 years oncology research experience OR
• Masters with 10 years oncology research experience OR
• Bachelors with 12 years oncology research experience AND 6 years of managerial experience

Mansioni

• Drive research strategy and execution for a differentiated oncology portfolio.
• Lead and develop high-performing teams of project leaders and scientists.
• Advance preclinical programs and partner cross-functionally with clinical development and biomarker teams.
• Leverage data and technology to accelerate discovery and decision-making.
• Shape external collaborations, including academic partnerships and business development opportunities.

Conoscenze

Oncology research

Team leadership

Strategy development

Cross-functional

Data analysis

Formazione

Doctorate

Masters

Bachelors

Descrizione del lavoro

Amgen is seeking an Executive Director of Oncology Research to lead the discovery and development of novel cancer therapies. You will drive strategy, build high-performing teams, and shape next-generation oncology programs, focusing on ADCs and beyond.

This high-visibility role offers opportunities to partner across functions and externally to advance medicines that improve patient lives. We value inclusive leadership, scientific excellence, and a patient-centric approach as we pursue a bold